NATASHA LASH: Open Payments
NPI 1356096572 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,700 in 154 payments from 17 companies in 2025. Trend: 2023 $2,039 · 2024 $809 · 2025 $2,700
Food & beverage: $2,700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $619 |
| Neurocrine BioSciences, Inc. | 31 | $293 |
| Teva Pharmaceuticals USA, Inc. | 12 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $272 |
| Axsome Therapeutics, Inc. | 12 | $203 |
| Otsuka America Pharmaceutical, Inc. | 13 | $189 |
| Vanda Pharmaceuticals Inc. | 7 | $167 |
| Collegium Pharmaceutical, Inc. | 9 | $142 |
| E.R. Squibb & Sons, L.L.C. | 7 | $135 |
| Lundbeck LLC | 4 | $94 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, AUSTEDO XR, REXULTI, Auvelity, FANAPT, Jornay PM.
Industry payments across IA — which companies pay providers there.
